Active: new fund Nov 2025 Verified 4 Nov 2026
Elevate Capital
Venture firm for overlooked founders, running funds from pre-seed to Series A and managing Oregon state programs. Fund I invests $25k to $100k, Fund II $100k up to $2 million. Listed location is Hillsboro, OR.
- Type
- VC firm
- Location
- Hillsboro, Oregon, United States
- Stages
- Pre-seed, Seed, Series A
- Backs
- B2B software, Consumer products, Medtech and digital health
- Sectors
- Healthtech and life sciences, Biotech, Climate and cleantech
- Fund size / AUM
- $200M Elevate Ventures Growth Fund I (Form D offering, 2025)
- Latest fund or filing
- 13 Nov 2025
- Portfolio mix
- B2B software 30%; Consumer products 27%; Medtech and digital health 13%; Fintech 10%; Climate and energy 7%; Biotech and pharma 7%; Hardware 3%; Consumer apps 3% (n=30)
- Website
- elevate.vc
Fund filings (SEC Form D)
- Latest fund on file
- Elevate Capital Fund III
- Filed
- 13 Nov 2025 (new notice)
- Fund size
- $50M (total offering)
- Fund vehicles filed in the last 12 months
- 1 (includes feeder and parallel vehicles)
See this fund's filings on SEC EDGAR
Contacts on file
For Elevate Capital, the paid file holds: 8 named decision-makers with roles; firm contact email (domain checked); how to pitch (the route the firm publishes); LinkedIn page.
Get US Complete, $197 Free sample
One-time payment. No subscription. No account.
Notable investments
BitesizeBlendoorbumpedCascade ProdrugCélage Bioscience
Sources
- www.sec.gov/Archives/edgar/data/2094009/000123191925000465/
- elevate.vc/
- www.sec.gov/Archives/edgar/data/2052720/000205272025000001/
- elevate.vc/team/
Last checked 4 Nov 2026. Is something wrong? Tell us.
Appears in 65 lists
Venture capital firms in Oregon (16)Series A CPG investors in the US (27)Pre-seed CPG investors in the US (35)Series A CPG investors (41)Pre-seed CPG investors (43)Series A biotech investors in the US (59)Series A climate tech investors in the US (60)Seed CPG investors in the US (73)Series A medtech investors in the US (76)Series A consumer investors in the US (80)Pre-seed biotech investors in the US (81)Pre-seed climate tech investors in the US (84)Pre-seed medtech investors in the US (95)Seed CPG investors (99)Pre-seed consumer investors in the US (104)Series A medtech investors (125)Pre-seed medtech investors (129)CPG venture capital firms in the US (130)Pre-seed biotech investors (148)Series A biotech investors (153)Series A consumer investors (154)Seed biotech investors in the US (159)Pre-seed consumer investors (162)Seed climate tech investors in the US (162)Series A healthtech investors in the US (164)CPG investors (165)Seed medtech investors in the US (205)Seed consumer investors in the US (216)Pre-seed healthtech investors in the US (225)Pre-seed climate tech investors (230)Climate tech venture capital firms in the US (256)Series A SaaS investors in the US (256)Series A climate tech investors (263)Seed medtech investors (278)Biotech venture capital firms in the US (297)Seed biotech investors (300)Seed consumer investors (331)Consumer venture capital firms in the US (348)Medtech venture capital firms in the US (350)Pre-seed SaaS investors in the US (367)Series A investors in the US (372)Series A healthtech investors (401)Pre-seed healthtech investors (408)Seed healthtech investors in the US (437)Medtech investors (457)Seed climate tech investors (458)Series A SaaS investors (475)Biotech investors (484)Consumer investors (512)Pre-seed investors in the US (549)Pre-seed SaaS investors (562)Climate tech investors (660)Seed SaaS investors in the US (666)Healthtech venture capital firms in the US (709)Seed healthtech investors (800)Series A investors (864)Pre-seed investors (988)Seed SaaS investors (1,010)Seed investors in the US (1,043)SaaS venture capital firms in the US (1,049)Healthtech investors (1,207)SaaS investors (1,529)Active venture capital firms in the US (1,574)Seed investors (1,892)Venture capital firms in the US (2,975)